
Study evaluates efficacy, immunogenicity, safety of the product to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.

Study evaluates efficacy, immunogenicity, safety of the product to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.

Device provides tailored relief to multiple pain areas and adds more treatment options for evolving conditions.

Joanna discusses her recommendations for sunscreen and what pharmacists picked as their favorite sunscreen product in the OTC Guide.

This month, we spoke with several interesting people in the pharmacy field, including the author of a children's book and hosts of a new podcast.

Brought to you by The Sassy Pharmacist

Tranexamic acid indicated for patients with hemophilia for short-term use to reduce or prevent hemorrhage and decrease the need for replacement therapy during and following tooth extraction.

Neutrogena On-the-Spot with benzoyl peroxide helps reduce treat acne breakouts.

New research suggests that icosapent ethyl can significantly decrease cardiovascular risk among former or current smokers with other cardiovascular risk factors.

Pregnant women with epilepsy showed more symptoms of anxiety and depression than healthy pregnant or non-pregnant women, but mental health screening may help.

Current cases of undiagnosed diabetes may be more prevalent in certain minority groups, obese and older adults.

New research indicates that COVID-19 vaccinations did not increase the risks of preterm births or gestational issues for pregnant women, despite prior conflicting evidence.

Risankizumab-rzaa is the first and only specific IL-23 inhibitor approved to treat moderately to severely active Crohn disease in adults.

Analysis shows that myocarditis was the most commonly diagnosed condition associated with pediatric post-acute sequelae of SARS-CoV-2.

How would you handle these patient questions?

FDA regulations under Food, Drug, and Cosmetic Act outline efficacy, safety requirements for animal pharmaceuticals.

Catherine Oakar, special assistant to the President for Public Health and Disparities in the Domestic Policy Council at The White House, discusses plans to address diet-related diseases in a conference held at The White House in September 2022.

Although the COVID-19 pandemic may have ostensibly required global populations to stand still, this stillness shrouded what was in fact a period of extensive acceleration.

Meropenem IV is an antibacterial medication indicated for the treatment of complicated stomach and skin structure infections.

Tioconazole is an antifungal agent indicated for yeast infections.

Although innovation in the pharmacy space is continuing nearly 3 years into the COVID-19 pandemic, provider status and reimbursement are both necessary to continue this innovation in the future.

In addition to garnering more public awareness in recent years, expert Michael Zimmerman said supply chain disruptions have “hyper-evolved” during the COVID-19 pandemic.

Although pharmacies have repeatedly proven their value and continue to be essential to providing equitable health care, Jason Ausili, PharmD, said commensurate reimbursement is necessary to move forward.

A panel at the National Association of Chain Drug Stores Total Store Expo discusses the importance of expanding parental leave policies for new parents as well as mentorship for women pursuing leadership positions.

Following the seemingly endless disruptions to the country’s supply chain over the past 2-year period, signs are showing more pain before things get better.

At the National Association of Chain Drug Stores (NACDS) 2022 Total Store Expo, Pharmacy Times spoke with Danny Sanchez, senior vice president and general manager of EnlivenHealth.

The disease can often be detected and managed early before a patient experiences signs or symptoms.

Additionally, approximately 70% who responded to the EnlivenHealth survey say that one-third or more of their revenue comes from individuals eligible for the government health insurance.

As more biosimilars and specialty generics enter the market next year, this could result in a shift in drug spending.

Pemigatinib is the first targeted therapy to gain FDA approval for the treatment of adult patients with relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement.

Yoona Kim, PharmD, PhD, co-founder and CEO of Arine, discusses some of the key takeaways from the launch of Mark Cuban's pharmacy Mark Cuban Cost Plus Drug Co.